<https://www.karyopharm.com/#logo>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>
<https://www.karyopharm.com/resources/preclinical-activity-non-hodgkins-lymphoma-selinexor-selective-inhibitor-nuclear-export-sine-enhanced-combination-standard-care-therapies/>